Scarica l'app Stockscreener
1.3712
3.01%
-0.0488
Hoth Therapeutics Inc Borsa (HOTH) Ultime notizie
Hoth Therapeutics expands cancer drug patent portfolio - MSN
HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal - MSN
Hoth Therapeutics Acquires New Patent Applications - Contract Pharma
Hoth Therapeutics Expands Cancer Drug Patent Portfolio, Strengthens HT-001 Development Strategy - StockTitan
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025 - PR Newswire
Hoth Therapeutics’ (HOTH) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More - MSN
Shares Of This Micro Cap More Than Doubled Today - MSN
3 Penny Stocks to Watch Now, 1/9/25 - TipRanks
Hoth Therapeutics maintains strong cash position, no offering plans By Investing.com - Investing.com Nigeria
Hoth Therapeutics Shares Recover; Company Has No Plans for Offering - MarketWatch
Hoth Therapeutics maintains strong cash position, no offering plans - Investing.com
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries - PR Newswire
S&P 500 E-Mini (ESM23) Quote - The Globe and Mail
Hoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s Excited - Asianet Newsable
Dow Jones Transportations Average (DOWT) QuotePress Release - The Globe and Mail
Dow Jones Global (DOWG) QuotePress Release - The Globe and Mail
Hoth reports 100% success in cancer skin toxicity trial By Investing.com - Investing.com South Africa
Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients - Mugglehead
Hoth Therapeutics stock hits 52-week high at $1.73 By Investing.com - Investing.com Australia
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
PHLX Euro FX (XDE) QuotePress Release - The Globe and Mail
TSX Composite Low Volatility (TXLV) QuotePress Release - The Globe and Mail
Hoth Therapeutics Soars 215% on Breakthrough Cancer Treatment Success - Yahoo Finance
Why Hoth Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register
Stock market news: Hoth Therapeutics +184.32%, DatChat +79.85% among top gainers during mid day trading - Business Upturn
Stock market news: SPI Energy saw rise of 276.74% while Hoth Therapeutics surged by 186.73% during mid day trading - Business Upturn
Nasdaq Down 1.5%; RPM Posts Upbeat Results - Benzinga
Hoth’s phase IIa derma data in cancer patients propels its stock - BioWorld Online
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday? - Benzinga
Hoth Therapeutics Shares Hit 52-Week High on Positive Data for Cancer Treatment - MarketWatch
Stock market today: XTI Aerospace surged by 108.52% while ACELYRIN posted fall of 38.68% in early trading - Business Upturn
Dow Surges Over 100 Points; US Trade Deficit Widens In November - Benzinga
Hoth Therapeutics stock hits 52-week high at $1.73 - Investing.com
Hoth reports 100% success in cancer skin toxicity trial - Investing.com
Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities - PR Newswire
Cero Therapeutics to effect 1-for-100 reverse stock split - Yahoo Finance
VA Enters Into Development Partnership with Hoth Therapeutics - The Presidential Prayer Team
Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Hoth acquires license to technology developed by the VA and Emory University - BioWorld Online
Hoth licenses patents to develop anti-obesity treatments - MSN
EGFR Inhibitors-Induced Skin Disorders Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment - Longview News-Journal
Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance
1.07%
8.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):